This website is for UK Healthcare Professionals only

Expert Opinion

 

Dr Raj Sengupta Unmet Needs in AS

Clinical Summary Videos

 

RINVOQ Discovery Journey & MOA

SELECT AXIS 1

Clinical Summaries

SELECT AXIS 1

Efficacy and safety of RINVOQ in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

UK-UPAD-220206. Date of preparation: August 2022

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to AbbVie on GBPV@abbvie.com